Higher discontinuation rates and lower maintenance doses compared to trials
Tirzepatide is a dual-action type 2 diabetes medication
Visit our Endocrinology Department at Continental Hospitals, Hyderabad, for expert evaluation, advanced care, and personalized treatment from our specialists
The goal is not to replace prescription treatment, but to evaluate Akkermansia as part of a broader microbiome-supportive strategy for people managing digestive changes during GLP-1 use
For example, semaglutide moves from 0.25 mg to 0.5 mg to 1.0 mg to 2.4 mg over approximately four months
In April 2025, Empower Pharmacy, a large 503B compounding pharmacy in the US, challenged Eli Lillys pharmaceutical exclusivity by filing a petition to invalidate Eli Lillys tirzepatide patent, arguing that the drug is unpatentable due to prior art